Fig. 3From: The efficacy and safety of high-dose nonsedating antihistamines in chronic spontaneous urticaria: a systematic review and meta-analysis of randomized clinical trialsA-1Â Forest plot of response rate comparing high-dose with standard-dose sgAHs.(subgroup by dose). A-2Â Forest plot of response rate comparing high-dose with standard-dose sgAHs.(subgroup by drug). B-1Â Forest plot of adverse events comparing high-dose with standard-dose sgAHs.(subgroup by dose). B-2Â Forest plot of adverse events comparing high-dose with standard-dose sgAHs.(subgroup by drug). C-1Â Forest plot of somnolence comparing high-dose with standard-dose sgAHs.(subgroup by dose). C-2Â Forest plot of somnolence comparing high-dose with standard-dose sgAHs.(subgroup by drug). D-1Â Forest plot of comparing withdrawal of patients due to adverse events between high-dose and standard-dose sgAHs treatment.(subgroup by dose). D-2Â Forest plot of comparing withdrawal of patients due to adverse events between high-dose and standard-dose sgAHs treatment.(subgroup by drug)Back to article page